157 related articles for article (PubMed ID: 26203609)
1. Managing dyspnea in advanced chronic obstructive pulmonary disease: balancing all the evidence.
Mularski RA; Rocker G
Ann Am Thorac Soc; 2015 Jul; 12(7):978-80. PubMed ID: 26203609
[No Abstract] [Full Text] [Related]
2. Effects of opioids on breathlessness and exercise capacity in chronic obstructive pulmonary disease. A systematic review.
Ekström M; Nilsson F; Abernethy AA; Currow DC
Ann Am Thorac Soc; 2015 Jul; 12(7):1079-92. PubMed ID: 25803110
[TBL] [Abstract][Full Text] [Related]
3. The need to address increasing opioid use in elderly COPD patients.
Vozoris NT; O'Donnell DE
Expert Rev Respir Med; 2016; 10(3):245-8. PubMed ID: 26783198
[No Abstract] [Full Text] [Related]
4. Inhaled fentanyl citrate improves exercise endurance during high-intensity constant work rate cycle exercise in chronic obstructive pulmonary disease.
Jensen D; Alsuhail A; Viola R; Dudgeon DJ; Webb KA; O'Donnell DE
J Pain Symptom Manage; 2012 Apr; 43(4):706-19. PubMed ID: 22168961
[TBL] [Abstract][Full Text] [Related]
5. Opioids, Chronic Obstructive Pulmonary Disease, and Hyperbole.
Vozoris NT
J Palliat Med; 2018 Jun; 21(6):745. PubMed ID: 29889015
[No Abstract] [Full Text] [Related]
6. The New "Opioid Crisis": Scientific Bias, Media Attention, and Potential Harms for Patients with Refractory Dyspnea.
Rocker G; Bourbeau J; Downar J
J Palliat Med; 2018 Feb; 21(2):120-122. PubMed ID: 29393775
[No Abstract] [Full Text] [Related]
7. New physiological insights into dyspnea and exercise intolerance in chronic obstructive pulmonary disease patients.
Laveneziana P; Guenette JA; Webb KA; O'Donnell DE
Expert Rev Respir Med; 2012 Dec; 6(6):651-62. PubMed ID: 23234451
[TBL] [Abstract][Full Text] [Related]
8. Opioid utility for dyspnea in chronic obstructive pulmonary disease: a complicated and controversial story.
Vozoris NT
Ann Palliat Med; 2020 Mar; 9(2):571-578. PubMed ID: 31865744
[TBL] [Abstract][Full Text] [Related]
9. Opioids for Dyspnea in Chronic Obstructive Pulmonary Disease: Short on the Details.
Vozoris NT
Am J Respir Crit Care Med; 2021 Jan; 203(2):266-267. PubMed ID: 33022187
[No Abstract] [Full Text] [Related]
10. Reply to Vozoris: Opioids for Dyspnea in Chronic Obstructive Pulmonary Disease: Short on the Details.
Mammen MJ; Charbek E; Alexander PE; Nici L; Aaron SD
Am J Respir Crit Care Med; 2021 Jan; 203(2):267-269. PubMed ID: 33022179
[No Abstract] [Full Text] [Related]
11. Chronic obstructive pulmonary disease: thinking outside the opioid box.
Liao S; Arnold RM
J Palliat Med; 2007 Jun; 10(3):781-2. PubMed ID: 17592990
[No Abstract] [Full Text] [Related]
12. The connection between chronic obstructive pulmonary disease symptoms and hyperinflation and its impact on exercise and function.
Cooper CB
Am J Med; 2006 Oct; 119(10 Suppl 1):21-31. PubMed ID: 16996896
[TBL] [Abstract][Full Text] [Related]
13. The dyspnea target: can we zero in on opioid responsiveness in advanced chronic obstructive pulmonary disease?
Horton R; Rocker G; Currow D
Curr Opin Support Palliat Care; 2010 Jun; 4(2):92-6. PubMed ID: 20443250
[TBL] [Abstract][Full Text] [Related]
14. Opioids for palliation of refractory dyspnea in chronic obstructive pulmonary disease patients.
Varkey B
Curr Opin Pulm Med; 2010 Mar; 16(2):150-4. PubMed ID: 20071992
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological management of breathlessness in COPD: recent advances and hopes for the future.
O'Donnell DE; Webb KA; Harle I; Neder JA
Expert Rev Respir Med; 2016 Jul; 10(7):823-34. PubMed ID: 27115291
[TBL] [Abstract][Full Text] [Related]
16. Managing dyspnea in patients with advanced chronic obstructive pulmonary disease: a Canadian Thoracic Society clinical practice guideline.
Marciniuk DD; Goodridge D; Hernandez P; Rocker G; Balter M; Bailey P; Ford G; Bourbeau J; O'Donnell DE; Maltais F; Mularski RA; Cave AJ; Mayers I; Kennedy V; Oliver TK; Brown C;
Can Respir J; 2011; 18(2):69-78. PubMed ID: 21499589
[TBL] [Abstract][Full Text] [Related]
17. Effect of tiotropium on neural respiratory drive during exercise in severe COPD.
Qin YY; Li RF; Wu GF; Zhu Z; Liu J; Zhou CZ; Guan WJ; Luo JY; Yu XX; Ou YM; Jiang M; Zhong NS; Luo YM
Pulm Pharmacol Ther; 2015 Feb; 30():51-6. PubMed ID: 25449059
[TBL] [Abstract][Full Text] [Related]
18. Gaps in Opioid Prescription for Severe Breathlessness in Hospitalized Patients With Chronic Obstructive Pulmonary Disease or Interstitial Lung Disease.
Chen X; Treanor D; Le B; Smallwood N
J Pain Symptom Manage; 2020 Sep; 60(3):e36-e39. PubMed ID: 32446973
[No Abstract] [Full Text] [Related]
19. Re: Liu et al., Effectiveness and safety of opioids on breathlessness and exercise endurance in patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis of randomised controlled trials.
Johnson MJ; Ekström M; Janssen DJ; Currow DC
Palliat Med; 2024 Mar; 38(3):400-401. PubMed ID: 38415671
[No Abstract] [Full Text] [Related]
20. Emerging opioid alternatives to nebulized fentanyl for improving exercise capacity in patients with COPD.
Kapoor S
J Pain Symptom Manage; 2012 Oct; 44(4):e1; author reply e1-2. PubMed ID: 23026483
[No Abstract] [Full Text] [Related]
[Next] [New Search]
